AYA OMGYES Sexual Health Study
Assessing the Impact of a Web-based Educational Program on the Sexual Health Outcomes of Young Adult Female Cancer Survivors ~ A Pilot Trial
University of Chicago
30 participants
Jan 16, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to assess the impact of the web-based intervention OMGYES.com on sexual dysfunction in young adult (YA) female-bodied cancer survivors. This pilot trial seeks to evaluate the intervention's: * feasibility * acceptability * appropriateness. Researchers will utilize an active observation period to compare outcomes between those receiving the intervention immediately and those who haven't Participants will: * Complete online modules at home * Visit the clinic every 5 weeks for questionnaires
Eligibility
Inclusion Criteria8
- Age 18 to 40 years
- Diagnosis of cancer between the ages of 15 and 40
- Female genitalia, regardless of gender
- Diagnosed with sexual dysfunction
- Complete Remission and at least two months from a major treatment
- Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
- Ability to participate in study modules and to respond to surveys
- Ability to understand and the willingness to sign a written informed consent document
Exclusion Criteria3
- Patients receiving other investigational agents
- Patients expected to be neutropenic or have a significantly high infection risk that would exclude them from vaginal penetration
- Patients who are unable complete the study intervention or surveys
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OMGYES.com is an interactive website that offers information, video tutorials, interviews, tips, and resources to explore female sexual pleasure through groundbreaking research that's told through the real-life experiences of women of all ages and life stages.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06868121